IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Zhang Q, Lapalus M, Asselah T, Laouénan C, Moucari R, Martinot-Peignoux M, Bieche I, Estrabaud E, De Muynck S, Boyer N, Bedossa P, Vidaud M, Marcellin P, Lada O.
Zhang Q, et al. Among authors: boyer n.
J Viral Hepat. 2014 Jul;21(7):525-32. doi: 10.1111/jvh.12177. Epub 2013 Oct 10.
J Viral Hepat. 2014.
PMID: 24118626